Irwin H. Gelman
Affiliations: | Roswell Park - Cellular and Molecular Biology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Cell BiologyGoogle:
"Irwin Gelman"Children
Sign in to add traineeYahao Bu | grad student | 2007 | SUNY Buffalo |
Sheila Figel | grad student | 2013 | SUNY Buffalo |
Hyun K. Ko | grad student | 2013 | SUNY Buffalo |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Miller KA, Degan S, Wang Y, et al. (2023) Correction: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression. Oncogene |
Miller KA, Degan S, Wang Y, et al. (2023) PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression. Oncogene |
Gelman IH. (2023) Metastasis suppressor genes in clinical practice: are they druggable? Cancer Metastasis Reviews. 42: 1169-1188 |
Miller K, Degan S, Wang Y, et al. (2023) PTEN regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression. Research Square |
Zhang J, Gelman IH, Qu J, et al. (2022) Phosphohistidine signaling promotes FAK-RB1 interaction and growth factor-independent proliferation of esophageal squamous cell carcinoma. Oncogene |
Katsuta E, Gil-Moore M, Moore J, et al. (2022) Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors. International Journal of Oncology. 61 |
Degan SE, Gelman IH. (2021) Emerging Roles for AKT Isoform Preference in Cancer Progression Pathways. Molecular Cancer Research : McR |
Zhang J, Gelman IH, Katsuta E, et al. (2019) Glucose drives growth factor-independent esophageal cancer proliferation via phosphohistidine-FAK signaling. Cellular and Molecular Gastroenterology and Hepatology |
McGrath JE, Panzica L, Ransom R, et al. (2019) Identification of genes regulating breast cancer dormancy in 3D bone endosteal niche cultures. Molecular Cancer Research : McR |
Gandhi S, Gil M, Khoury T, et al. (2019) Abstract P2-06-17: A novel interaction of AURKA with MAPK pathway in breast cancer cells as a potential therapeutic target Cancer Research. 79 |